IP Library › Assignment 033788/0539
Patent Assignment
Reel/Frame 033788/0539

Assignment of Assignor's Interest

Recorded: 2014-09-22 Pages: 23
Assignor
EGEN, INC.
Executed: 2014-06-17
Assignee
CLSN LABORATORIES, INC.
C/O CORPORATION SERVICE COMPANY, 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON, DELAWARE, 19808
Covered Properties (33)
Hepatocyte Targeting Polyethylene Glyco-Grafted Poly-L-Lysine Polymeric Gene Carrier
Patent: 6,177,274 →
Application: 09/315,240 →
Polyester Analogue of Poly-L-Lysine as a Soluble, Biodegradable Gene Delivery Carrier
Patent: 6,217,912 →
Application: 09/352,473 →
Novel Cationic Lipopolymer as Biocompatible Gene Delivery Agent
Patent: 6,696,038 →
Application: 09/662,511 →
Biodegradable Cationic Copolymers of Poly (Alkylenimine) and Poly (Ethylene Glycol) for the Delivery of Bioactive Agents
Patent: 6,652,886 →
Application: 09/785,525 →
Publication: US 2002/0141965
Cellular Targeting Poly(Ethylene Glycol)-Grafted Polymeric Gene Carrier
Patent: 6,586,524 →
Application: 09/909,418 →
Publication: US 2003/0018002
Glp-1 Gene Delivery for the Treatment of Type 2 Diabetes
Patent: 7,374,930 →
Application: 10/153,470 →
Publication: US 2003/0220274
Novel cationic lipopolymer as a biocompatible gene delivery agent
Application: 10/717,109 →
Publication: US 2004/0142474
Biodegradable Cross-Linked Cationic Multi-Block Copolymers for Gene Delivery and Methods of Making Thereof
Patent: 8,057,821 →
Application: 10/981,135 →
Publication: US 2006/0093674
Combination of Immuno Gene Therapy & Chemotherapy for Treatment of Cancer & Hyperproliferative Diseases
Patent: 7,964,571 →
Application: 11/261,931 →
Publication: US 2006/0127482
GLP-1 gene delivery for the treatment of type 2 diabetes
Application: 12/074,865 →
Publication: US 2009/0227660
Nucleic Acid-Lipopolymer Compositions
Application: 12/186,945 →
Publication: US 2009/0042829
Modified Poloxamers for Gene Expression and Associated Methods
Application: 12/395,240 →
Publication: US 2010/0004313
Biodegradable Cross-Linked Branched Poly(Alkylene Imines)
Application: 12/404,989 →
Publication: US 2010/0004315
Compositions and Methods for the Delivery of Biologically Active Rnas
Patent: 8,569,065 →
Application: 12/724,408 →
Publication: US 2010/0233141
Polyamine Derivatives
Patent: 8,460,696 →
Application: 12/727,987 →
Publication: US 2010/0260817
Combination of Immuno Gene Therapy and Chemotherapy for Treatment of Cancer and Hyperproliferative Diseases
Patent: 8,623,837 →
Application: 13/109,473 →
Publication: US 2011/0218231
Biodegradable Cross-Linked Cationic Multi-Block Copolymers for Gene Delivery and Methods of Making Thereof
Patent: 8,445,017 →
Application: 13/237,168 →
Publication: US 2012/0009145
Nucleic Acid-Lipopolymer Compositions
Patent: 9,144,546 →
Application: 13/605,462 →
Publication: US 2013/0065942
Compositions and Methods for the Delivery of Biologically Active RNAs
Application: 13/726,337 →
Publication: US 2013/0164845
Polyamine Derivatives
Patent: 8,900,621 →
Application: 13/790,980 →
Publication: US 2014/0050775
Polyamine Derivatives
Patent: 8,932,638 →
Application: 13/791,102 →
Publication: US 2013/0251809
Compositions and methods for the Delivery of Biologically Active RNAs
Application: 13/793,961 →
Publication: US 2014/0005254
Immuno Gene Therapy for Treatment of Cancer and Hyperproliferative Diseases
Patent: 9,468,687 →
Application: 14/147,674 →
Publication: US 2014/0186375
Lactose-Polyethylene Glycol-Grafted Poly-L-Lysine as Hepatoma Cell- Targeted Gene Carrier
Application: 60/086,072 →
Polyester Analogue of Poly-L--Lysine as a Biodegradable Gene Delivery Carrier
Application: 60/092,682 →
Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases
Application: 60/635,042 →
Biodegradable Cross-Linked Cationic Multi-Block Copolymers for Gene Delivery and Associated Methods
Application: 61/036,775 →
Modified poloxamers for gene expression and associated methods
Application: 61/067,607 →
Compositions And Methods For The Delivery Of Biologically Active RNAs
Application: 61/160,287 →
Compositions And Methods For The Delivery Of Biologically Active RNAs
Application: 61/160,288 →
Polyamine Derivatives
Application: 61/161,828 →
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
Application: 61/190,065 →
Publication: US 2009/0042825
Compositions and Methods For The Delivery of Biologically Active RNAs
Application: 61/579,815 →
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 1, 2000
From: MAHATO, RAM I.; HAN, SANG-OH; FURGESON, DARIN Y.
To: EXPRESSION GENETICS, INC.
Reel/Frame 011304/0799 →
Assignment of Assignor's Interest Sep 4, 2001
From: AHN, CHEOL HEE
To: EXPRESSION GENETICS
Reel/Frame 012150/0626 →
Assignment of Assignor's Interest Jan 18, 2002
From: SAGARA, KAZUYOSHI
To: EXPRESSION GENETICS, INC.
Reel/Frame 012504/0740 →
Assignment of Assignor's Interest Aug 30, 2002
From: OH, SEUNGJOON; LEE, MINHYUNG; KO, KYUNGSOO
To: EXPRESSION GENETICS, INC.
Reel/Frame 013245/0406 →
Assignment of Assignor's Interest Nov 19, 2003
From: MAHATO, RAM I.; HAN, SANG-OH; FURGESON, DARIN Y.; ANWER, KHURSHEED
To: EXPRESSION GENETICS, INC.
Reel/Frame 014728/0962 →
Assignment of Assignor's Interest Jan 24, 2005
From: SLOBODKIN, GREGORY; MATAR, MAJED; FEWELL, JASON; ANWER, KHURSHEED
To: EXPRESSION GENETICS, INCORPORATED
Reel/Frame 016194/0994 →
Assignment of Assignor's Interest Dec 23, 2005
From: FEWELL, JASON G.; MATAR, MAJED; RICE, JENNIFER; LEWIS, DANNY H.
To: EXPRESSION GENETICS
Reel/Frame 017402/0676 →
Assignment of Assignor's Interest Sep 11, 2009
From: SLOBODKIN, GREGORY; MATAR, MAJED; SPARKS, BRIAN JEFFERY; FEWELL, JASON
To: EGEN, INC.
Reel/Frame 023219/0458 →
Assignment of Assignor's Interest Sep 11, 2009
From: SLOBODKIN, GREGORY; MATAR, MAJED; SPARKS, BRIAN JEFFERY; FEWELL, JASON
To: EGEN, INC.
Reel/Frame 023219/0416 →
Assignment of Assignor's Interest Apr 30, 2010
From: MATAR, MAJED; FEWELL, JASON; LEWIS, DANNY H.; ANWER, KHURSHEED
To: EGEN, INC.
Reel/Frame 024316/0544 →
Assignment of Assignor's Interest Jun 23, 2010
From: SLOBODKIN, GREGORY; CONGO, RICHARD; MATAR, MAJED; FEWELL, JASON
To: EGEN, INC.
Reel/Frame 024583/0074 →
Assignment of Assignor's Interest Sep 29, 2010
From: POLACH, KEVIN; FEWELL, JASON; ANWER, KHURSHEED
To: EGEN, INC.
Reel/Frame 025063/0305 →
Change of Name May 11, 2011
From: EXPRESSION GENETICS, INC.
To: EGEN, INC.
Reel/Frame 026257/0834 →
Change of Name May 17, 2011
From: EXPRESSION GENETICS, INC.
To: EGEN, INC.
Reel/Frame 026293/0316 →
Assignment of Assignor's Interest May 17, 2011
From: FEWELL, JASON; MATAR, MAJED; RICE, JENNIFER; LEWIS, DANNY
To: EXPRESSION GENETICS, INC.
Reel/Frame 026292/0730 →
Assignment of Assignor's Interest Jul 20, 2011
From: OH, SEUNGJOON; LEE, MINHYUNG; KO, KYUNGSOO
To: EXPRESSION GENETICS, INC.
Reel/Frame 026622/0719 →
Assignment of Assignor's Interest Jul 20, 2011
From: PARK, JONG-SANG; CHOI, YOUNG HUN; LIU, FENG
To: EXPRESSION GENETICS, INC.
Reel/Frame 026622/0697 →
Assignment of Assignor's Interest Jul 20, 2011
From: PARK, JONG-SANG; CHOI, YOUNG HUN; KIM, SUNG WAN
To: EXPRESSION GENETICS, INC.
Reel/Frame 026622/0666 →
Change of Name Jul 27, 2011
From: EXPRESSION GENETICS, INC.
To: EGEN, INC.
Reel/Frame 026656/0425 →
Assignment of Assignor's Interest Sep 29, 2011
From: SLOBODKIN, GREGORY; MATAR, MAJED; FEWELL, JASON; ANWER, KHURSHEED
To: EXPRESSION GENETICS, INC.
Reel/Frame 026991/0697 →
Change of Name Sep 29, 2011
From: EXPRESSION GENETICS, INC.
To: EGEN, INC.
Reel/Frame 026991/0703 →
Assignment of Assignor's Interest Jan 21, 2013
From: POLACH, KEVIN; FEWELL, JASON; ANWER, KHURSHEED; WILKINSON, LESLIE
To: EGEN, INC.
Reel/Frame 029665/0191 →
Assignment of Assignor's Interest Apr 25, 2014
From: SLOBODKIN, GREGORY; CONGO, RICHARD; MATAR, MAJED; FEWELL, JASON
To: EGEN, INC.
Reel/Frame 032761/0640 →
Assignment of Assignor's Interest Jun 2, 2014
From: MATAR, MAJED; FEWELL, JASON; LEWIS, DANNY H.; ANWER, KHURSHEED
To: EGEN, INC.
Reel/Frame 033009/0031 →